Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Spectral Medical Inc.TSX: EDT.TO

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income dips below year-ago levels

Q1 FY2026 net income of CA$2.94M (cash outflow) fell 76.7% year over year, behind the +59.5% change in trailing-twelve-month net income. Sequentially, it rose 3.5% from the prior quarter. Over 3 fiscal years it compounded at +61.8% a year.

Context

  • Net income amounted to 1953.0% of revenue in FY2025, up 1279.5 pp from a year earlier.
  • Net income grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of -CA$402.09K (-99.2%) for the fiscal year ending Dec 2026, a slowdown from the +209.8% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$2.94M+3.5% QoQ
Last fiscal yearDec 2025
-CA$47.69M+209.8% YoY
LTMMar 2026
-CA$38.02M+59.5% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-76.7%+77.3%+154.0 pp
1 year+209.8%-99.2%-308.9 pp
3-year CAGR+61.8%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CAD · from the cash flow

Latest · FY2025
(47.69M) CAD
Year-over-year change
-209.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +59.5% is the 4th highest of 8, against a peer median of +20.4%.
  • Net income amounts to 1377.1% of revenue for EDT.TO, versus a peer median of 39.1%.
EDT.TO Competitors
Net Income for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$263.55M CAD-56.4%-28.6%84.8%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$50.24M CAD-418.7%-39.5%15.8%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$42.94M USD+85.5%+18.4%—
PRN.TOProfound Medical Corp.LTM Mar 2026$38.94M USD+20.4%+14.1%207.6%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$38.02M CAD+59.5%+61.8%1377.1%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$31.07M USD+236.1%+0.9%61.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$8.81M USD-39.0%-25.7%17.2%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$8.44M CAD+276.1%-36.4%12.7%
Peer median (excluding EDT.TO) —+20.4%-25.7%39.1%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.79M)(11.25M)(15.66M)(15.4M)(47.69M)
Depreciation & Amortization294K272K218K251K250K
Deferred Income Tax00000
Stock-Based Compensation1.26M1.2M1.49M1.68M2.12M
Change in Working Capital(1.76M)579K(406K)1.01M(189K)
Accounts Receivables55K(877K)870K(265K)246K
Inventory(51K)(47K)(26K)137K(148K)
Accounts Payables(1.11M)1.65M(267K)(51K)(265K)
Other Working Capital(656K)(142K)(983K)1.19M(22K)
Other Non-Cash Items288K(698K)3.64M3.64M33.88M
Operating Cash Flow(8.7M)(9.9M)(10.72M)(8.82M)(9.52M)
Capital Expenditures(483K)(33K)(185K)(27K)(195K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities158K0000
Investing Cash Flow(325K)(33K)(185K)(27K)(195K)
Debt Repayment(113K)3.71M3.93M9.74M9.67M
Common Stock Issued10M4.03M01.15M3.4M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.28M1.72M1.51M(2.02M)(155K)
Financing Cash Flow12.17M9.46M5.44M8.88M12.91M
Effect of Forex Changes(56K)0000
Net Change in Cash3.08M(476K)(5.46M)36K1.08M
Free Cash Flow(9.18M)(9.93M)(10.91M)(8.85M)(9.72M)

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.